What labs are recommended to assess female hormone deficiency?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 23, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Laboratory Assessment for Female Hormone Deficiency

Measure FSH and LH on cycle days 3-6 (ideally averaged from three samples taken 20 minutes apart), mid-luteal progesterone, estradiol, TSH, and prolactin as your core hormone panel. 1

Core Hormone Panel

FSH and LH (Days 3-6 of Cycle)

  • Draw between cycle days 3-6 to capture baseline gonadotropin levels before follicular recruitment begins 2, 1
  • For maximum accuracy, calculate the average of three blood draws taken 20 minutes apart 2, 1
  • FSH >35 IU/L and LH >11 IU/L indicate ovarian failure (hypergonadotropic hypogonadism) 2, 1
  • LH/FSH ratio >2 suggests polycystic ovary syndrome (PCOS) and likely anovulation 2, 1
  • LH <7 IU/mL may indicate hypothalamic dysfunction 2, 1
  • FSH on days 1-2 is the best single predictor of ovarian reserve when comparing reproductive age groups 3

Progesterone (Mid-Luteal Phase)

  • Progesterone <6 nmol/L indicates anovulation and is the most reliable hormonal indicator of ovulation 2, 1
  • Blood must be drawn during mid-luteal phase according to the menstrual cycle 2

Estradiol (Days 3-6 of Cycle)

  • Measure on days 3-6 alongside FSH/LH as it is essential for assessing ovarian function 1
  • Low estradiol with elevated FSH confirms ovarian insufficiency 1
  • Normal to high estradiol with elevated LH/FSH ratio supports PCOS diagnosis 1

TSH

  • TSH is essential as thyroid dysfunction commonly causes menstrual irregularity and must be excluded 2, 1

Prolactin

  • Measure in morning resting samples (not postictal) 2, 1
  • Prolactin >20 μg/L is abnormal and warrants investigation for hypothyroidism or pituitary tumor 2, 1

Additional Testing Based on Clinical Context

Testosterone and Androgens (Days 3-6)

  • Testosterone >2.5 nmol/L suggests PCOS or valproate effect 2
  • Androstenedione >10.0 nmol/L requires exclusion of adrenal/ovarian tumor 2
  • DHEAS elevation (age 20-29: >3800 ng/mL; age 30-39: >2700 ng/mL) suggests non-classical congenital adrenal hyperplasia 2

Glucose and Insulin

  • Fasting glucose >7.8 mmol/L suggests diabetes 2
  • Glucose/insulin ratio >4 suggests reduced insulin sensitivity associated with obesity and PCOS 2

Anti-Müllerian Hormone (AMH)

  • For women with irregular or absent cycles, AMH does not vary by menstrual day and is not affected by exogenous estrogen or progesterone 1
  • Interpret with caution in women under age 25 due to significant fluctuations 1

Critical Pitfalls to Avoid

  • Wrong cycle phase timing renders results uninterpretable 1
  • Discontinue hormonal contraceptives at least 2 months before testing as they suppress normal FSH and LH patterns 1
  • Antiepileptic drugs can impact hormone levels and cause reproductive endocrine disorders 2, 1
  • Prolactin should never be measured postictal as it will be spuriously elevated 2

Pattern Recognition for Diagnosis

PCOS Pattern

  • LH/FSH ratio >2, elevated LH throughout cycle, normal to high estradiol 1
  • Low mid-luteal progesterone indicating anovulation 2, 1

Functional Hypothalamic Amenorrhea Pattern

  • Low gonadotropins, LH/FSH ratio <1, low estradiol with thin endometrium 1

Ovarian Failure Pattern

  • FSH >35 IU/L, LH >11 IU/L, low estradiol 2, 1

When to Refer to Endocrinology/Gynecology

  • Prepubertal females with no signs of puberty by age 13 years 1
  • Primary amenorrhea by age 16 years 1
  • Postpubertal females with menstrual cycle dysfunction suggestive of premature ovarian insufficiency 1
  • Any patient diagnosed with ovarian insufficiency requiring sex steroid replacement therapy consideration 1

References

Guideline

Hormonal Testing for Female Reproductive Dysfunction

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.